首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Monoclonal antibodies raised against 167–180 aa sequence of human carbonic anhydrase XII inhibit its enzymatic activity
【24h】

Monoclonal antibodies raised against 167–180 aa sequence of human carbonic anhydrase XII inhibit its enzymatic activity

机译:抗人碳酸酐酶XII 167-180aa序列的单克隆抗体抑制其酶活性

获取原文
           

摘要

Human carbonic anhydrase XII (CA XII) is a single-pass transmembrane protein with an extracellular catalytic domain. This enzyme is being recognized as a potential biomarker for different tumours. The current study was aimed to generate monoclonal antibodies (MAbs) neutralizing the enzymatic activity of CA XII. Bioinformatics analysis of CA XII structure revealed surface-exposed sequences located in a proximity of its catalytic centre. Two MAbs against the selected antigenic peptide spanning 167–180 aa sequence of CA XII were generated. The MAbs were reactive with recombinant catalytic domain of CA XII expressed either in E. coli or mammalian cells. Inhibitory activity of the MAbs was demonstrated by a stopped flow CO2 hydration assay. The study provides new data on the surface-exposed linear CA XII epitope that may serve as a target for inhibitory antibodies with a potential immunotherapeutic application.
机译:人碳酸酐酶XII(CA XII)是具有细胞外催化结构域的单程跨膜蛋白。该酶被认为是不同肿瘤的潜在生物标志物。当前的研究旨在产生中和CA XII酶促活性的单克隆抗体(MAb)。 CA XII结构的生物信息学分析显示,位于其催化中心附近的表面暴露序列。产生了两个针对CA XII 167-180氨基酸序列的选定抗原肽的单克隆抗体。 MAb与在大肠杆菌或哺乳动物细胞中表达的CA XII的重组催化结构域反应。停止流动的CO 2 水化试验证明了单克隆抗体的抑制活性。这项研究提供了有关表面暴露的线性CA XII表位的新数据,这些表位可能用作具有潜在免疫治疗应用的抑制性抗体的靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号